Related references
Note: Only part of the references are listed.Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis
Angela M. Starks et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin
Hassan Safi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China
Ruiru Shi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis
Xin Shen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited:: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance
MH Hazbón et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol
LA Parsons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Laboratory diagnostic aspects of drug resistant tuberculosis
LM Parsons et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis
BV Nikonenko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol
H Lee et al.
YONSEI MEDICAL JOURNAL (2002)
Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis
SV Ramaswamy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
